NDTVCenter·
AI-Generated Drug Shows Early Signs Of Slowing Aging: Report
The drug, rentosertib, was originally developed to treat idiopathic pulmonary fibrosis (IPF), a progressive scarring disease of the lungs, and was tested on 42 patients over 12 weeks in a Phase 2a trial.
Read at NDTV →



